Viking Therapeutics (NASDAQ ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Trading Halts

Viking Therapeutics (VKTX) Announces Proposed Common Share OfferingSeptember 19, 2018 4:23 PM Viking Therapeutic (VKTX) PT Raised to $28 at SunTrust Robinson HumphreySeptember 18, 2018 3:39 PM Viking Therapeutic (VKTX) PT Raised to $28 at Maxim Group, Matching 'Street High'September 18, 2018 12:31 PM Viking Therapeutic (VKTX) PT Raised to 'Street High' $28 at H.C. WainwrightSeptember 18, 2018 11:57 AM Viking Therapeutics (VKTX) Climbs 140% After Shares Resume TradingSeptember 18, 2018 7:37 AM Viking Therapeutics (VKTX) Says Phase 2 Study of VK2809 in Patients with NAFLD and Elevated LDL-Cholesterol Achieved its Primary EndpointSeptember 18, 2018 7:08 AM Viking Therapeutics Announces Positive Top-Line Results from Phase 2 Study of VK2809 in Patients with Non-Alcoholic Fatty Liver Disease (NAFLD) and Elevated LDL-CholesterolSeptember 18, 2018 7:05 AM Viking Therapeutics (VKTX) Halted, News PendingSeptember 18, 2018 7:00 AM